AFP and hepatocellular carcinoma: To address this deficiency of protein biomarkers for liver cancer detection, a combination of markers (i.e., AFP, osteopontin, and DKK1) has been shown to make improvements in the sensitivity and specificity of HCC diagnosis [82].